about
Understanding migraine: Potential role of neurogenic inflammationBotulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersPathophysiological links between traumatic brain injury and post-traumatic headachesRelevance of functional neuroimaging studies for understanding migraine mechanisms.Primary headaches and trigeminal neuralgia: neuropathic pain yes or not? Evidences from neurophysiological procedures.The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal.Calcitonin gene-related peptide antagonism for acute treatment of migraine: a meta-analysis.Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway.The omics in migraine.Prevalence and clinical characteristics of headache among medical students, Isfahan, Iran.Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.The pathophysiological and pharmacological basis of current drug treatment of migraine headache.Post-traumatic headaches in civilians and military personnel: a comparative, clinical review.What is the evidence for the use of corticosteroids in migraine?Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers.Investigation of the metabolic biotransformation of substance P in liver microsomes by liquid chromatography quadrupole ion trap mass spectrometry.Glutamate receptor antagonists with the potential for migraine treatment.
P2860
Q26747000-1293A3DB-84CB-40E3-B4DD-2270956F4C59Q26781281-B9C86D17-B18B-45E9-AD4F-4C7FD45B7F9AQ28067288-225977AC-6FD5-4AB4-834E-2215AF73489DQ30596099-A6ACA6CC-7F43-4C0B-9910-87AB35F93CB3Q34952863-5AD191ED-E9C5-45E3-B577-AD6214CFCE60Q35541053-1C6D188E-C4CD-49D1-B4A1-09BFCEE95DE3Q35884646-340AE558-0AF5-4CD3-8A21-80D59958833BQ36506877-8A05073E-9BFD-40DC-A0C2-4FE8A780ED2AQ37056740-F2F4EE35-BE2C-49EE-88B7-05CD7B433924Q37094994-BE929648-19BC-40B4-B56C-3F3386A33F8FQ37686124-C08BF0B4-34DF-4AB5-91EA-D65FC7A9DA58Q37713262-725FFC0F-DB19-4DD9-9BFE-042A540EF2F7Q38105147-B5E02057-08FB-486C-9893-B1CFAA763569Q38110585-6880EF1D-308B-40F1-85E1-7A609CE9CC70Q38265392-DC1EEF67-8B66-4268-90A9-87F595401AA5Q43885764-AD1ED3A4-C7B9-4405-A8EB-6D804E56FCBAQ44603236-D34CC4C3-80E7-4FC5-B189-4B5F0E2C7825Q47627647-F35B2020-9A63-420E-BD68-61EB4D3C009E
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antidromic vasodilatation and the migraine mechanism.
@en
Antidromic vasodilatation and the migraine mechanism.
@nl
type
label
Antidromic vasodilatation and the migraine mechanism.
@en
Antidromic vasodilatation and the migraine mechanism.
@nl
prefLabel
Antidromic vasodilatation and the migraine mechanism.
@en
Antidromic vasodilatation and the migraine mechanism.
@nl
P2093
P2860
P1476
Antidromic vasodilatation and the migraine mechanism.
@en
P2093
Alberto Chiarugi
Eleonora Rossi
Pierangelo Geppetti
P2860
P2888
P304
P356
10.1007/S10194-011-0408-3
P577
2011-12-27T00:00:00Z
2012-03-01T00:00:00Z